Subscribe to RSS
DOI: 10.1055/s-0043-1775881
Mortality from Breast Cancer in Women under 50 Years of Age in Colombia
Mortalidade por câncer de mama em mulheres com menos de 50 anos de idade na ColômbiaAbstract
Objective To calculate and analyze the mortality rates from breast cancer in women under 50 years of age in Colombia and to compare them with those of other countries in the region.
Methods Based on data from the registry of deaths in 2018 and the results of the National Population and Housing Census of Colombia for the same year, specific mortality rates in women with breast cancer, specific mortality according to age group, standardized by age, proportional mortality, potential years of life lost, and years of life expectancy lost in women under 50 years of age who died from breast cancer were calculated. The mortality rate of regional countries was consulted on the Global Cancer Observatory webpage.
Results In the group from 20 to 49 years, the specific mortality rate was higher in the age range from 45 to 49 years, with a rate of 23.42 × 100,000, a value that was above the specific mortality rate due to breast cancer in women in Colombia, 15.17 × 100.000. In the age range of 45 to 49 years, the potential years of life lost were 42.16. Of the 0.275 years of life expectancy lost by the population due to this neoplasia, women under 50 years of age represented 0.091 (33%). Colombia is the fifth in the rank of mortality in Latin American countries in this age group.
Conclusion Breast cancer in patients from 30 to 59 years is the number one cause for the decrease in life expectancy of women in Colombia. Women under 50 years of age represent one third of this decrease. This neoplasm is also the leading cause of mortality in women younger than 50 years in South America.
Publication History
Received: 01 June 2023
Accepted: 08 August 2023
Article published online:
23 December 2023
© 2023. Federação Brasileira de Ginecologia e Obstetrícia. This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/)
Thieme Revinter Publicações Ltda.
Rua do Matoso 170, Rio de Janeiro, RJ, CEP 20270-135, Brazil
-
References
- 1 Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2021; 71 (03) 209-249
- 2 Global Cancer Observatory. World Health Organization. Cancer Today. https://gco.iarc.fr Accessed 2023 January 15.
- 3 Paluch-Shimon S, Cardoso F, Partridge AH, Abulkhair O, Azim Jr HA, Bianchi-Micheli G. et al. ESO-ESMO 4th International Consensus Guidelines for Breast Cancer in Young Women (BCY4). Ann Oncol 2020; 31 (06) 674-696
- 4 Assi HA, Khoury KE, Dbouk H, Khalil LE, Mouhieddine TH, El Saghir NS. Epidemiology and prognosis of breast cancer in young women. J Thorac Dis 2013; 5 (Suppl 1, Suppl 1) S2-S8
- 5 Zhong W, Tan L, Jiang WG, Chen K, You N, Sanders AJ. et al. Effect of younger age on survival outcomes in T1N0M0 breast cancer: A propensity score matching analysis. J Surg Oncol 2019; 119 (08) 1039-1046
- 6 Azim Jr HA, Partridge AH. Biology of breast cancer in young women. Breast Cancer Res 2014; 16 (04) 427
- 7 Anastasiadi Z, Lianos GD, Ignatiadou E, Harissis HV, Mitsis M. Breast cancer in young women: an overview. Updates Surg 2017; 69 (03) 313-317
- 8 Ruddy KJ, Gelber S, Tamimi RM, Schapira L, Come SE, Meyer ME. et al. Breast cancer presentation and diagnostic delays in young women. Cancer 2014; 120 (01) 20-25
- 9 Partridge AH, Hughes ME, Ottesen RA, Wong YN, Edge SB, Theriault RL. et al. The effect of age on delay in diagnosis and stage of breast cancer. Oncologist 2012; 17 (06) 775-782 2011–0469
- 10 Ekwueme DU, Trogdon JG, Khavjou OA, Guy Jr GP. Productivity costs associated with breast cancer among survivors aged 18–44 years. Am J Prev Med 2016; 50 (02) 286-294
- 11 Ekwueme DU, Allaire BT, Guy Jr GP, Arnold S, Trogdon JG. Treatment costs of breast cancer among younger women aged 19–44 years enrolled in Medicaid. Am J Prev Med 2016; 50 (02) 278-285
- 12 Allaire BT, Ekwueme DU, Guy Jr GP, Li C, Tangka FK, Trivers KF. et al. Medical care costs of breast cancer in privately insured women aged 18–44 years. Am J Prev Med 2016; 50 (02) 270-277
- 13 Paalman CH, van Leeuwen FE, Aaronson NK, de Boer AGEM, van de Poll-Franse L, Oldenburg HSA, Schaapveld M. Employment and social benefits up to 10 years after breast cancer diagnosis: a population-based study. Br J Cancer 2016; 114 (01) 81-87
- 14 Ganz PA, Greendale GA, Petersen L, Kahn B, Bower JE. Breast cancer in younger women: reproductive and late health effects of treatment. J Clin Oncol 2003; 21 (22) 4184-4193
- 15 Kroenke CH, Rosner B, Chen WY, Kawachi I, Colditz GA, Holmes MD. Functional impact of breast cancer by age at diagnosis. J Clin Oncol 2004; 22 (10) 1849-1856
- 16 Villarreal-Garza C, Aguila C, Magallanes-Hoyos MC, Mohar A, Bargalló E, Meneses A. et al. Breast cancer in young women in Latin America: an unmet, growing burden. Oncologist 2013; 18 (12) 1298-1306
- 17 Carioli G, Bertuccio P, Malvezzi M, Rodriguez T, Levi F, Boffetta P. et al. Cancer mortality predictions for 2019 in Latin America. Int J Cancer 2020; 147 (03) 619-632
- 18 Fondo Colombiano de Enfermedades de Alto Costo, Cuenta de Alto Costo (CAC). The situation of cancer in the adult population attended in the SGSSS of Colombia 2019; pp. 45. Bogotá D.C. ISSN: 2539–2301. https://cuentadealtocosto.org/site/wpcontent/uploads/2020/09/CANCER2019COM-3.pdf Accessed 2023 January 15. (Spanish)
- 19 Departamento Nacional de Estadística(DANE). Deaths by age group and sex, according to departments of occurrence and groups of causes of death (Colombia 105 list for mortality tabulation). Year 2018. https://www.dane.gov.co/index.php/estadisticas-por-tema/salud/nacimientos-y-defunciones/defunciones-no-fetales/defunciones-no-fetales-2018 Accessed 2023 January 15. (Spanish).
- 20 Departamento Nacional de Estadística(DANE). National Population and Housing Census of Colombia 2018. https://www.dane.gov.co/index.php/estadisticas-por-tema/demografia-y-poblacion/censo-nacional-de-poblacion-y-vivenda-2018 Accessed 2023 January 15.(Spanish).
- 21 Departamento Nacional de Estadística(DANE) 2022. Applied Sociodemographic Statistics Reports. Number 15. Years of life expectancy lost 2017 - 2019: A regional analysis and by age groups. ISSN: 2805–6345(online). https://www.dane.gov.co/files/investigaciones/poblacion/informes-estadisticas-sociodemograficas/2022-06-17-nos_de_Esperanza_Vida_Perdidos_2019.pdf29 Accessed 2023 January 16.(Spanish).
- 22 Pan American Health Organization (PAHO). Basic guidelines for the analysis of mortality. Washington, D.C.: OPS; 2017. http://iris.paho.org Accessed 2023 January 15. (Spanish).
- 23 Pan American Health Organization (PAHO) 2009. Age-standardized death rates per population of 100,000. https://www.paho.org/hq/dmdocuments/2010/Tasas-de-mortalidad-por-edad-estandarizadas-hoja-de-resumen.pdf Accessed 2023 January 15. (Spanish).
- 24 Celentano DD, Szklo M. The Occurrence of Disease: II. Mortality and Other Measures of Disease Impact. En: Gordis Epidemiology, Celentano DD, Szklo M. Sixth Edition. Elsevier 2019. ISBN: 978–0-323–55229–5. pp:65–93
- 25 Cavazos-Ortega N, del Río-Zolezzi A, Izazola-Lícea JA, Lezana-Fernández MA, Valdespino-Gómez JL. [Years of potential life lost: their usefulness in the analysis of mortality in Mexico]. Salud Publica Mex 1989; 31 (05) 610-624 (Spanish)
- 26 Arriaga EE. Measuring and explaining the change in life expectancies. Demography 1984; 21 (01) 83-96
- 27 GLOBOCAN. 2020: New Global Cancer Data. Union for International Cancer Control. https://www.uicc.org/news/globocan-2020-new-global-cancer-data#:∼:text=What%20is%20GLOBOCAN%3F,for%20all%20cancer%20sites%20combined
- 28 Evilla-Olmos JM, Álvarez-Beltrán WA, Velásquez-García Y, Garrido-Zea EF, Escudero-Cardona DE, Bonilla-Sepúlveda OA. Intrinsic subtypes of breast cancer and prognostic factors in a reference center in Medellin, Colombia. A descriptive study. Medicina Laboratorio 2023; 27: 199-209
- 29 Ossa Gómez CA, Gómez Wolff LR, Ascuntar Tello J, García García HI. Overall and disease-free survival base on the intrinsic molecular subtype of a cohort of 2,200 patients with breast cancer – experience at a Colombian comprehensive cancer center. Rev Medica Sanitas 2015; 18 (03) 122-132
- 30 Rocha-Brischiliari SC, Oliveira RR, Andrade L, Brischiliari A, Gravena AAF, Carvalho MDB, Pelloso SM. The rise in mortality from breast cancer in young women: trend analysis in Brazil. PLoS One 2017; 12 (01) e0168950
- 31 Strasser-Weippl K, Chavarri-Guerra Y, Villarreal-Garza C, Bychkovsky BL, Debiasi M, Liedke PER. et al. Progress and remaining challenges for cancer control in Latin America and the Caribbean. Lancet Oncol 2015; 16 (14) 1405-1438
- 32 Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin 2011; 61 (02) 69-90
- 33 Cecilio AP, Takakura ET, Jumes JJ. et al. Breast cancer in Brazil: epidemiology and treatment challenges. Breast Cancer (Dove Med Press) 2015; 7: 43-49
- 34 OECD/The World Bank. 2020. Health Panorama: Latin America and the Caribbean 2020. OECD Publishing; Paris: https://doi.org/10.1787/740f9640-es (Spanish).
- 35 Silva JDDE, de Oliveira RR, da Silva MT, Carvalho MDB, Pedroso RB, Pelloso SM. Breast Cancer Mortality in Young Women in Brazil. Front Oncol 2021; 10: 569933
- 36 Santos SdaS, Melo LR, Koifman RJ, Koifman S. Breast cancer incidence and mortality in women under 50 years of age in Brazil. Cad Saude Publica 2013; 29 (11) 2230-2240
- 37 Cendales R, Pardo C. Quality of death certification in Colombia. Colomb Med (Cali) 2018; 49 (01) 121-127